Your browser doesn't support javascript.
loading
Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.
Modvig, S; Madsen, H O; Siitonen, S M; Rosthøj, S; Tierens, A; Juvonen, V; Osnes, L T N; Vålerhaugen, H; Hultdin, M; Thörn, I; Matuzeviciene, R; Stoskus, M; Marincevic, M; Fogelstrand, L; Lilleorg, A; Toft, N; Jónsson, O G; Pruunsild, K; Vaitkeviciene, G; Vettenranta, K; Lund, B; Abrahamsson, J; Schmiegelow, K; Marquart, H V.
Afiliação
  • Modvig S; Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Madsen HO; Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Siitonen SM; Helsinki University Ctrl. Hospital, Helsinki, Finland.
  • Rosthøj S; Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
  • Tierens A; Laboratory Medicine Program, University Health Network and University of Toronto, Toronto, ON, Canada.
  • Juvonen V; Department of Pathology, University Hospital of Oslo, Oslo, Norway.
  • Osnes LTN; Department of Clinical Chemistry and Laboratory Division, University of Turku and Turku University Hospital, Turku, Finland.
  • Vålerhaugen H; Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Hultdin M; Department of Pathology, Laboratory of Molecular Pathology, Oslo University Hospital, Oslo, Norway.
  • Thörn I; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
  • Matuzeviciene R; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Stoskus M; Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Marincevic M; Centre of Laboratory Medicine, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Fogelstrand L; Hematology, Oncology and Transfusion Medicine Centre, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
  • Lilleorg A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Toft N; Department of Clinical Chemistry, Sahlgrenska University Hospital, and Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Jónsson OG; Department of Clinical Immunology, North Estonia Medical Centre, Tallinn, Estonia.
  • Pruunsild K; Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Vaitkeviciene G; Children's Hospital, Landspitali University Hospital, Reykjavik, Iceland.
  • Vettenranta K; Tallinn Children's Hospital, Tallinn, Estonia.
  • Lund B; Children's Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
  • Abrahamsson J; Department of Pediatrics, Helsinki University Children's Hospital and University of Helsinki, Helsinki, Finland.
  • Schmiegelow K; Department of Pediatrics, St. Olavs University Hospital and Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway.
  • Marquart HV; Institution of Clinical Sciences, Department of Pediatrics, Sahlgrenska University Hospital, Gothenburg, Sweden.
Leukemia ; 33(6): 1324-1336, 2019 06.
Article em En | MEDLINE | ID: mdl-30552401
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Medição de Risco / Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Citometria de Fluxo / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Medição de Risco / Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Citometria de Fluxo / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Leukemia Ano de publicação: 2019 Tipo de documento: Article